Antidepressants fail, but no cause for therapeutic gloom

The Lancet

Volumn 388, Issue 10047, 2016, Pages 844-845

  Jureidini, Jon ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE;

CLINICAL TRIAL; DRUG TREATMENT FAILURE; HUMAN; NOTE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY;

ANTIDEPRESSIVE AGENTS; HUMANS;

EID: 84987638591     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30585-2     Document Type: Note

References (5)

1. 1 Cipriani, A, Zhou, X, Del Giovane, C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet, 2016 published online June 8. http://dx.doi.org/10.1016/S0140-6736(16)30385-3.
2. 2 Jureidini, J, Amsterdam, J, McHenry, LB, The Citalopram CIT-MD-18 Pediatric Depression Trial: deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance. Int J Risk Saf Med 28 (2016), 33–43.
3. 3 Le Noury, J, Nardo, JM, Healy, D, et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ, 351, 2015, h4320.
4. 4 Jureidini, J, Let children cry. Med J Aust 201 (2014), 612–613.
5. 5 Batstra, L, Frances, A, Diagnostic inflation: causes and a suggested cure. J Nerv Ment Dis 200 (2012), 474–479.